Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia – a propensity score analysis

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Sasaki, Koji, Kantarjian, Hagop, Jabbour, Elias, Ravandi, Farhad, Takahashi, Koichi, Konopleva, Marina, Borthakur, Gautam, Garcia-Manero, Guillermo, Wierda, William, Daver, Naval, Jain, Preetesh, Satta, Toshihisa, Pierce, Sherry, Rios, May Beth, Cortes, Jorge E.
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2016
Materias:
Online Only Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967581/
https://ncbi.nlm.nih.gov/pubmed/27175025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.139089
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares